Last update 23 Jan 2025

FOLR1 x TRPV6 x Top I

Basic Info

Related Targets
FOLR1TRPV6Top I

Related

1
Drugs associated with FOLR1 x TRPV6 x Top I
CBP-1019
Target
FOLR1 x TRPV6 x Top I
Mechanism
FOLR1 antagonists [+2]
Active Org.
Coherent Biopharma Suzhou Co., Ltd.Coherent Biopharma Suzhou Co., Ltd.Startup [+1]
Originator Org.
Coherent Biopharma Suzhou Co., Ltd.Coherent Biopharma Suzhou Co., Ltd.Startup
Active Indication
Advanced Malignant Solid Neoplasm [+11]
Inactive Indication-
Drug Highest PhasePhase 1/2
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
4
Clinical Trials associated with FOLR1 x TRPV6 x Top I
NCT06576037
/ RecruitingPhase 1IIT
Phase Ib Study of CBP-1019 in Combination with FOLFOX +/- Bevacizumab, Pembrolizumab, or Enzalutamide for Metastatic TRPV6-overexpressing Solid Tumors of Epithelial Origin
100 Clinical Results associated with FOLR1 x TRPV6 x Top I
Login to view more data
100 Translational Medicine associated with FOLR1 x TRPV6 x Top I
Login to view more data
0 Patents (Medical) associated with FOLR1 x TRPV6 x Top I
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free